Voveran SR is a sustained-release formulation of the non-steroidal anti-inflammatory drug diclofenac sodium. It is prescribed to relieve pain and inflammation in conditions such as arthritis and musculoskeletal disorders. The active ingredient diclofenac works by inhibiting the cyclooxygenase enzymes cox-1 and cox-2, which reduces the production of prostaglandins responsible for mediating pain and fever. By lowering prostaglandin levels in peripheral tissues, the medication decreases swelling, redness, and discomfort associated with inflammation. The sustained-release design allows a gradual release of diclofenac into the bloodstream, maintaining therapeutic concentrations over an extended period. This prolonged exposure supports continuous symptom control while minimizing the frequency of dosing.

Voveran SR is a sustained-release formulation of the non-steroidal anti-inflammatory drug diclofenac. It is used to relieve pain and inflammation in conditions such as osteoarthritis and rheumatoid arthritis. The drug belongs to the class of cox inhibitors that reduce the production of prostaglandins involved in pain signaling. By blocking cox enzymes the medication decreases the synthesis of inflammatory mediators at the site of tissue injury. The sustained-release technology allows the active ingredient to be absorbed slowly into the bloodstream over several hours. This gradual release maintains steady drug levels and prolongs the anti-inflammatory effect without requiring frequent dosing. The pharmacokinetics of Voveran SR show a delayed onset but a prolonged duration of action compared with immediate-release diclofenac. The overall therapeutic effect results from the reduced prostaglandin activity which diminishes swelling pain and fever

Headache may occur as a common side effect of Voveran SR. Dizziness can be reported by some patients. Nausea is occasionally observed. Fatigue may be experienced. Elevated liver enzymes are a possible laboratory finding. Skin rash or itching may develop. Increased blood pressure has been noted in rare cases. Some individuals may experience abdominal discomfort.

Voveran SR may cause nausea or vomiting in some patients. Headache is also reported as a frequent complaint. Dizziness can occur, especially when changing positions. Some users experience abdominal pain or indigestion. Skin reactions such as rash or itching may develop. Elevated liver enzymes have been observed in occasional cases. Swelling of the ankles or feet may appear in rare instances.